PharmaLundensis
0,34 SEK
-1,15 %
Mindre end 1K følgere
PHAL
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Oversigt
Finansielt overblik og estimater
Ejerskab
Investorkonsensus
-1,15 %
-24,89 %
+45,76 %
-14,00 %
-44,04 %
-30,47 %
-54,00 %
-57,04 %
-89,51 %
PharmaLundensis is a research company. The company's main focus is on the treatment of serious lung diseases. Diseases that the company specializes in include chronic obstructive pulmonary disease (COPD), chronic bronchitis, and influenza-induced pulmonary failure. In addition to its main business, technical systems for handling drug emissions are developed. PharmaLundensis has its headquarters in Lund.
Læs mereMarkedsværdi
20,64 mio. SEK
Aktieomsætning
9,78 t SEK
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin
Omsætning
EBIT-% (adj.)
EPS og udbytte
EPS (adj.)
Udbytte %
Finanskalender
19.2
2026
Årsrapport '25